Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04790617
What this trial is testing

ENCOMPASS: Expansion Study B, RCT

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 183
Large-scale testing (Phase 3)Study completedNCT05167825
What this trial is testing

Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K. 7
Not applicableStudy completedNCT00926523
What this trial is testing

Biomarkers in the Evaluation of Chronic Lung Disease

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Northwell Health 67
Testing effectiveness (Phase 2)Study completedNCT01457781
What this trial is testing

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Bellerophon Pulse Technologies 80
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Not applicableUnknownNCT01071967
What this trial is testing

Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults

Who this might be right for
Heart FailureCoronary DiseaseDiabetes Mellitus+3 more
Health Quality Partners 2,000
Not applicableStudy completedNCT06550648
What this trial is testing

Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cairo University 78
Very early researchLooking for participantsNCT07662655
What this trial is testing

Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

Who this might be right for
Pulmonary HypertensionPulmonary Hypertension Associated With HFpEF
Xiamen Cardiovascular Hospital, Xiamen University 60
Post-approval studies (Phase 4)Study completedNCT02847260
What this trial is testing

Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 39
Early research (Phase 1)Study completedNCT06048120
What this trial is testing

Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Who this might be right for
Pulmonary Hypertension Due to Left Heart Disease
Bayer 82
Not applicableStudy completedNCT06819059
What this trial is testing

Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease

Who this might be right for
Congenital AbnormalitiesPulmonary Arterial Hypertension (PAH)Orthotopic Heart Transplant+4 more
Columbia University 50
Early research (Phase 1)Study completedNCT00023296
What this trial is testing

Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension

Who this might be right for
Sickle Cell AnemiaPulmonary Hypertension
National Heart, Lung, and Blood Institute (NHLBI) 59
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Not applicableWithdrawnNCT03833323
What this trial is testing

Implantable System for Remodulin Post-Approval Study

Who this might be right for
Pulmonary Arterial Hypertension
Medtronic Cardiac Rhythm and Heart Failure
Testing effectiveness (Phase 2)Study completedNCT04266197
What this trial is testing

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

Who this might be right for
Pulmonary Arterial Hypertension
Respira Therapeutics, Inc. 42
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Large-scale testing (Phase 3)Ended earlyNCT03496623
What this trial is testing

Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
United Therapeutics 188
Not applicableLooking for participantsNCT07337850
What this trial is testing

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre 60
Testing effectiveness (Phase 2)Ended earlyNCT00041574
What this trial is testing

Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide

Who this might be right for
Pulmonary HypertensionLung DiseaseSickle Cell Disease+2 more
Mallinckrodt 7
Large-scale testing (Phase 3)Study completedNCT00091598
What this trial is testing

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 372
Next Page